Jazz Pharmaceuticals (NASDAQ:JAZZ) Stock Rating Reaffirmed by Needham & Company LLC
Jazz Pharmaceuticals (NASDAQ:JAZZ – Get Free Report)‘s stock had its “buy” rating reaffirmed by research analysts at Needham & Company LLC in a research report issued on Wednesday, Benzinga reports. They currently have a $220.00 target price on the specialty pharmaceutical company’s stock. Needham & Company LLC’s target price points to a potential upside of […]
More Stories
California Leads Nation in Diesel Price Spike
By Bill Pan Diesel prices are rising across the nation, and California is taking an especially hard hit, as recent...
Trump Endorses Steve Hilton in Heated Race for California Governor
By Jill McLaughlin Republican Steve Hilton captured President Donald Trump’s endorsement on April 5 in his quest to become the...
Race to Secure Iran Cease-Fire Intensifies as Trump Ultimatum Ticks Down
By Chris Summers Efforts to revive cease-fire negotiations between the United States and Iran intensified on April 6 as regional...
Is Resume Genius Legit? Pricing, Features, and Cancellation Policy
Whether you are a working professional or a student, in your life, you must have searched for an online resume...
How Career-Focused College Scholarships for Students Help Today’s Graduates Afford College and Hit the Workforce Job-Ready
College is a big investment, and students want more than a diploma. They want a fair price and a clear...
Trump Threatens to Target Iran’s Bridges, Power Plants on April 7 if Strait of Hormuz Not Reopened
By Jacki Thrapp U.S. President Donald Trump has threatened to target Iran’s power plants and bridges on April 7 if...